Malcova LLC
- UEI
- JT6NDMA2JAC5
- CAGE
- 89Z63
- Primary NAICS
- 339112 Surgical and Medical Instrument Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Patient-specific narrow beam breast CT - executive summary opportunity - breast cancer is the most common malignancy… | National Cancer Institute | $1,365,000 | |
| Development of patient-derived anthropomorphic breast phantoms for automated objective assessment of breast x-RAY… | National Cancer Institute | $400,000 | |
| Sbir phase i: narrow-beam dedicated breast computed tomography | Division of Industrial Innovation | $245,000 |
About Malcova LLC
Malcova LLC is a corporate entity registered as a minority-owned, self-certified small disadvantaged business, and limited liability company that manufactures goods. It is involved in developing imaging technologies for breast cancer detection and screening.
Through federal contract awards, Malcova LLC has primarily provided research and development services related to breast imaging systems. In 2020, the National Cancer Institute awarded Malcova LLC a $452,397 firm-fixed-price contract set aside for small businesses. The contract called for developing patient-derived anthropomorphic breast phantoms to objectively assess breast X-ray imaging systems. This supported the National Institutes of Health and Centers for Disease Control and Prevention's mission through a 2019 solicitation seeking proposals for cancer imaging tools and technologies. The contract work was performed in Baltimore over approximately 21 months, concluding in May 2022.
Malcova LLC has received two federal grant awards from the National Cancer Institute and National Science Foundation for developing a narrow-beam dedicated breast computed tomography system. In 2022, the National Cancer Institute awarded a $1,365,000 project grant for work on patient-specific narrow-beam breast CT, including developing a fluence modulation assembly, line detector assembly, and image acquisition protocol. This grant supports the goal of creating a simultaneous bilateral breast cancer imaging platform for effective screening, particularly for women with dense breasts. Previously in 2020, the National Science Foundation awarded a $245,000 Phase I SBIR grant for narrow-beam dedicated breast computed tomography research and development. The grant awards have funded Malcova LLC's efforts to create an alternative breast imaging modality that addresses limitations of mammography, tomosynthesis, ultrasound, and MRI.
Quick answers
What is Malcova LLC's UEI?
Malcova LLC's Unique Entity ID (UEI) in SAM.gov is JT6NDMA2JAC5.
What is Malcova LLC's CAGE code?
Malcova LLC's CAGE code is 89Z63.
What is Malcova LLC's primary NAICS code?
Malcova LLC's primary NAICS code is 339112 (Surgical and Medical Instrument Manufacturing).
Is Malcova LLC registered in SAM.gov?
Malcova LLC's SAM.gov registration expired on November 29, 2022.
What is Malcova LLC's most recent federal award?
Malcova LLC's most recent federal grant award is Patient-specific narrow beam breast CT - executive summary opportunity - breast cancer is the most common malignancy… (R43CA261381), from National Cancer Institute, on February 28, 2022.
On GovTribe
See Malcova LLC's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors